However, CSF t-tau and p-tau decreased in PSP patients compared with healthy control, and lower baseline p-tau was associated with more rapid progression of disease, suggesting a different tau pathogenesis from AD [135]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.